News

AliveCor Press Release MOUNTAIN VIEW, Calif., Jan. 13, 2026 – AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the next generation of...

SCOTTSDALE, Ariz., January 13, 2026 – Innovative Health, Inc. today announced that the company has received its 50th clearance from FDA to reprocess single-use medical devices used in electrophysiology and cardiology labs. This latest...

Abbott Park, Ill., Jan. 12, 2026 — Abbott today announced a collaboration with AtaCor Medical to advance a next-generation investigational extravascular implantable cardioverter defibrillator (EV-ICD) system designed to deliver defibrillation...

  YorLabs Press Release  BEAVERTON, Ore., Jan. 12, 2026 -- YorLabs, Inc., a medical technology company pioneering next-generation intracardiac imaging solutions for electrophysiology (EP) and interventional cardiology...

AccurKardia Press Release NEW YORK -- AccurKardia, an ECG-led diagnostics software company focused on transforming ECG data into a more powerful diagnostic tool and broad biomarker to improve patient outcomes and save lives, today...

LUMA Vision Press Release DUBLIN, Jan. 7, 2026 -- LUMA Vision Ltd., a leader in cardiac 4D navigation and imaging, today announced the successful completion of 15 VERAFEYE™-guided persistent atrial fibrillation (AF) ablation...

European Society of Cardiology Press Release Sophia Antipolis 6 January 2026: Atrial fibrillation (AF) is the most common cardiac arrhythmia and is linked to stroke, heart failure, and other serious complications. It affects millions...

HUYABIO International Press Release SAN DIEGO, Jan. 6, 2026 -- HUYABIO International today announced favorable Phase 1 clinical data for HBI-3000, a novel bioinspired investigational drug with promising antiarrhythmic properties,...

Pulse Biosciences Press Release HAYWARD, Calif. -- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today...

Acesion Pharma Press Release COPENHAGEN, Denmark, Jan. 6, 2026 -- Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering treatments for atrial fibrillation ("AF"), the most common cardiac arrhythmia, today announces...